SCHEMBL4980205

SCHEMBL4980205

COc1ccc(-c2ccccc2OCCCCCOc2cccc(N(S)C(N)=O)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 4/20 0.42
SYK P43405 1/20 0.42
AURKB Q96GD4 1/20 0.42
INCENP Q9NQS7 1/20 0.42
FFAR4 Q5NUL3 1/20 0.41
LTB4R Q15722 1/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
MTNR1A P48039 5/20 0.39
MTNR1B P49286 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4982625 0.91 KDM4E (0.42) L3MBTL1TDP1LMNAMAPK1HTT
SCHEMBL4267805 0.91 KDM4E (0.48) L3MBTL1TDP1LMNAMAPK1HTT
SCHEMBL4983235 0.90 KDM4E (0.41) LMNAKDM4EFFAR4LTB4RMTNR1A
SCHEMBL3974854 0.90 KDM4E (0.49) L3MBTL1TDP1LMNAMAPK1HTT
SCHEMBL4982648 0.89 FABP4 (0.41) LMNAKDM4EFFAR4LTB4RMTNR1A
SCHEMBL4979327 0.88 FFAR1 (0.46) FFAR4LTB4RMTNR1AMTNR1B
SCHEMBL3980259 0.87 KDM4E (0.46) L3MBTL1TDP1LMNAMAPK1HTT
SCHEMBL4237783 0.87 LMNA (0.47) L3MBTL1TDP1LMNAMEN1CYP1A2
SCHEMBL4981179 0.87 MTNR1A (0.46) MTNR1AMTNR1B
SCHEMBL3984320 0.86 PTGDR2 (0.42) L3MBTL1KDM4EFFAR4LTB4RMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 L3MBTL1 822/4885TDP1 3021/4885LMNA 4873/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 L3MBTL1 720/4885TDP1 2622/4885LMNA 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.